nach oben

Erschienen in:

02.01.2019 | Research Article

Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

verfasst von: Ling Wang, Ying Wang, Jiong Hu, Yuqian Sun, He Huang, Jing Chen, Jianyong Li, Jun Ma, Juan Li, Yingmin Liang, Jianmin Wang, Yan Li, Kang Yu, Jianda Hu, Jie Jin, Chun Wang, Depei Wu, Yang Xiao, Xiaojun Huang

Erschienen in: Frontiers of Medicine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Titel: Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study
verfasst von: Ling Wang
Ying Wang
Jiong Hu
Yuqian Sun
He Huang
Jing Chen
Jianyong Li
Jun Ma
Juan Li
Yingmin Liang
Jianmin Wang
Yan Li
Kang Yu
Jianda Hu
Jie Jin
Chun Wang
Depei Wu
Yang Xiao
Xiaojun Huang
Publikationsdatum: 02.01.2019
Verlag: Higher Education Press
Erschienen in: Frontiers of Medicine / Ausgabe 3/2019
Print ISSN: 2095-0217
Elektronische ISSN: 2095-0225
DOI: https://doi.org/10.1007/s11684-018-0641-0

Springer Medizin

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Histone variants: critical determinants in tumour heterogeneity

Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety

Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia

Cytokines and inflammation in adipogenesis: an updated review

Erratum to: Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection

Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats